Venus Remedies Limited Total Liabilities
Venus Remedies Limited total liabilities. Based on the latest financial reports, Venus Remedies Limited (VENUSREM) has total liabilities worth Rs1.74 Billion INR (≈ $18.79 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Venus Remedies Limited (VENUSREM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Venus Remedies Limited (2006–2025)
Total liabilities of Venus Remedies Limited from 2006 to 2025. This chart illustrates how Venus Remedies Limited's total liabilities have evolved over time, based on quarterly financial data. Explore VENUSREM strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Venus Remedies Limited Competitors by Total Liabilities
The table below lists competitors of Venus Remedies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alfas Solar Enerji Sanayi ve Ticaret A.S.
IS:ALFAS
|
Turkey | TL6.48 Billion |
|
Eaton Vance Municipal Income Term Closed Fund
NYSE:ETX
|
USA | $8.33 Million |
|
QuantaSing Group Limited American Depositary Shares
NASDAQ:QSG
|
USA | $335.14 Million |
|
AVY Precision Technology
TWO:5392
|
Taiwan | NT$7.36 Billion |
|
Ledesma SAAI
BA:LEDE
|
Argentina | AR$331.45 Billion |
|
Kross Ltd
NSE:KROSS
|
India | Rs1.49 Billion |
|
Digital Currency X Technology Inc.
NASDAQ:DCX
|
USA | $709.20 Million |
|
Camlin Fine Sciences Limited
NSE:CAMLINFINE
|
India | Rs11.77 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Venus Remedies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see VENUSREM asset base.
Liquidity & Leverage Metrics
Venus Remedies Limited Total Liabilities Ratios Explained
Venus Remedies Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.15 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Venus Remedies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Venus Remedies Limited (2006–2025)
The table below shows the annual total liabilities of Venus Remedies Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs1.55 Billion ≈ $16.74 Million |
+11.13% |
| 2024-03-31 | Rs1.39 Billion ≈ $15.06 Million |
-1.04% |
| 2023-03-31 | Rs1.41 Billion ≈ $15.22 Million |
+0.98% |
| 2022-03-31 | Rs1.39 Billion ≈ $15.07 Million |
-10.41% |
| 2021-03-31 | Rs1.56 Billion ≈ $16.82 Million |
-50.51% |
| 2020-03-31 | Rs3.14 Billion ≈ $34.00 Million |
-21.47% |
| 2019-03-31 | Rs4.00 Billion ≈ $43.29 Million |
+2.92% |
| 2018-03-31 | Rs3.89 Billion ≈ $42.06 Million |
+3.03% |
| 2017-03-31 | Rs3.78 Billion ≈ $40.83 Million |
-6.83% |
| 2016-03-31 | Rs4.05 Billion ≈ $43.82 Million |
+5.42% |
| 2015-03-31 | Rs3.84 Billion ≈ $41.57 Million |
+3.12% |
| 2014-03-31 | Rs3.73 Billion ≈ $40.31 Million |
+10.14% |
| 2013-03-31 | Rs3.38 Billion ≈ $36.60 Million |
+26.88% |
| 2012-03-31 | Rs2.67 Billion ≈ $28.85 Million |
+19.11% |
| 2011-03-31 | Rs2.24 Billion ≈ $24.22 Million |
+25.17% |
| 2010-03-31 | Rs1.79 Billion ≈ $19.35 Million |
+13.16% |
| 2009-03-31 | Rs1.58 Billion ≈ $17.10 Million |
+32.74% |
| 2008-03-31 | Rs1.19 Billion ≈ $12.88 Million |
+18.59% |
| 2007-03-31 | Rs1.00 Billion ≈ $10.86 Million |
+231.12% |
| 2006-03-31 | Rs303.32 Million ≈ $3.28 Million |
-- |
About Venus Remedies Limited
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormo… Read more